- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Menopausal Hormone Therapy Linked to Better Bone Health in Postmenopausal Women: Study

Mexico: A retrospective cohort study found that menopausal hormone therapy was associated with a significantly lower risk of reduced bone mineral density (BMD) in postmenopausal women. Among 387 women evaluated, low BMD—defined as osteopenia or osteoporosis—was observed in only 31.8% of women receiving hormone therapy compared with 56.2% of those not using hormone therapy. These findings suggest that menopausal hormone therapy may play an important role in preserving bone health and reducing the risk of bone loss after menopause.
The findings were presented at ENDO 2026 by Diego Espinoza, a clinical researcher affiliated with INMEDS and SMNE, Hermosillo, Mexico.
Declining estrogen levels after menopause accelerate bone loss and increase the risk of osteopenia and osteoporosis. Although menopausal hormone therapy (MHT) is known to support bone health, concerns related to earlier regulatory warnings have limited its use. Recent updates to these warnings have renewed interest in evaluating their benefits for bone preservation.
To assess this association, researchers conducted a retrospective cohort study of 387 postmenopausal women who underwent DXA scans between 2021 and 2025. Among them, 129 women used MHT and 258 did not. Bone health was classified according to World Health Organization criteria, and factors associated with low bone mineral density were analyzed.
Key findings from the study include:
- Low bone mineral density was identified in 48.1% of the overall study population.
- Women receiving menopausal hormone therapy had significantly higher lumbar spine BMD than non-users (mean T-score: −0.62 vs −1.02).
- Total hip BMD was also significantly higher among hormone therapy users (mean T-score: −0.32 vs −0.81).
- The prevalence of low BMD was substantially lower among women using MHT (31.8%) compared with non-users (56.2%).
- After adjusting for age, years since menopause, body mass index, vitamin D levels, smoking status, and metabolic conditions, MHT use was associated with a 69% reduction in the odds of low BMD.
- Longer time since menopause was linked to a higher risk of low BMD, with risk increasing by approximately 9% for each additional year.
- Smoking more than doubled the likelihood of low BMD.
- Higher vitamin D levels were associated with a lower risk of reduced bone density.
The researchers concluded that menopausal hormone therapy was independently associated with higher bone mineral density and substantially lower odds of osteopenia or osteoporosis in postmenopausal women. The findings suggest that, beyond its established role in managing menopausal symptoms, MHT may offer significant benefits for bone preservation when used in appropriately selected women.
The authors noted that hormone therapy could represent an underused strategy for protecting skeletal health, particularly during the early years after menopause, when interventions may have the greatest impact on preventing future bone loss and fracture risk.
Reference:
ORF34-05 - Menopausal Hormone Therapy Is Associated with a 69% Lower Risk of Low Bone Mineral Density in Postmenopausal Women: A Retrospective Cohort Study
MSc. Biotechnology
Medha Baranwal holds a Bachelor’s degree in Biomedical Sciences from the University of Delhi and a Master’s degree in Biotechnology from Amity University. Since May 2018, she has been contributing to Medical Dialogues, writing and editing medical news articles that translate complex research into clear, accessible information for healthcare professionals.
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751

